SHENZHEN, China, Dec. 31, 2025 — UTime Limited (Nasdaq: WTO), a global technology firm involved in the design and development of mobile devices, on this day announced a significant commercial breakthrough. UTime’s Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially inked a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, an entity based in Denver. This marks a crucial step in UTime’s strategic layout in the North American medical – grade smart wearable market.
Under the signed Sales Agreement, Tumu Vertex LLC has placed an initial purchase order for 50,000 high – end smart health devices from UTime, which include:
- 25,000 units of the UT – 168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring.
- 25,000 units of the UT – 368 4G Blood Pressure Watch and 25,000 units of the UR01 Smart Ring
We think this collaboration not only represents a volume breakthrough but also elevates us to a new level in technological integration. UTime’s solution seamlessly combines FDA – certified medical – grade monitoring technology with daily wearable scenarios, representing the latest development trend in the smart health industry. The agreement adheres to internationally recognized trade frameworks, covering FOB Hong Kong delivery, phased payments, and standardized quality assurance systems.
“This cooperation is a significant strategic breakthrough for us in the North American market,” UTime’s CEO stated during the signing ceremony. “As our important partner in Colorado, Tumu Vertex’s order of 50,000 units not only shows market recognition of our technological capabilities but also opens the door to the North American medical – grade wearable market. We aim to take this opportunity to speed up the development and implementation of next – generation health monitoring technologies as part of our product portfolio.”
The founder and Chief Executive Officer of Tumu Vertex LLC, Monil Hossain, commented: “UTime’s technological innovation and product quality have greatly impressed us. These devices will be used for our smart health service platform in the United States, offering users 24/7 health monitoring solutions. We look forward to establishing long – term strategic cooperation with UTime.”
According to the agreement, the first batch of products will start being delivered in the first quarter of 2026, and all products will go through the joint quality control procedures established by both parties.
As the global population is living longer and becoming more health – conscious, UTime believes the smart health device market is set for explosive growth. We believe this major purchase order will help strengthen UTime’s position in the consumer electronics field while laying a solid foundation for the company’s strategic growth in the medical technology sector.
About UTime Limited
Trading under the NASDAQ ticker WTO, UTime Limited is engaged in the design, development, production, sales, and brand operation of mobile devices, smart wearable devices, and other technologies in China and globally. The company aims to offer cost – effective products while serving a wide customer base.
Safe Harbor Statement
This press release contains forward – looking statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than those of historical fact are forward – looking statements. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company’s actual results, performance, or achievements to differ materially from any future results, performances, or achievements expressed or implied by the forward – looking statements. For additional risk factors, please review UTime Limited’s Annual Report on Form 20 – F and other SEC filings. Forward – looking statements are made only as of the date of this release. The Company has no obligation to publicly update or revise any forward – looking statements, whether due to new information, future events, or otherwise, except as required by applicable law.
Contact:
UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 865122
